Indole and indazole analogs as glycogen synthase activators

Details Indole and indazole analogs as glycogen synthase activators Indole and indazole analogs as glycogen synthase activators

2011-05-24

2011-05-24

Loewe, Sun Jae Y (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S412000, C548S361100, C548S469000

Reexamination Certificate

active

07947728

ABSTRACT:
Provided herein are compounds of the formula (I):as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of metabolic diseases and disorders such as, for example, type II diabetes mellitus.

REFERENCES:
patent: 2004/0266856 (2004-12-01), Chu et al.
patent: 2005/0095219 (2005-05-01), Yang et al.
patent: 2842243 (1980-10-01), None
patent: 4142514 (1993-06-01), None
patent: 9740017 (1997-10-01), None
patent: 2004058679 (2004-07-01), None
patent: 2005000781 (2005-01-01), None
patent: 2006058648 (2006-06-01), None
patent: 2007024922 (2007-03-01), None
patent: 2007044622 (2007-04-01), None
patent: 2008033455 (2008-03-01), None
Terasaka et al., caplus an 2006:32063.
International Search Report for Corresponding Appl. PCT/EP2010/066868 filed Jan. 14, 2011.

Affiliated with

Also associated with

Rating

Indole and indazole analogs as glycogen synthase activators does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Indole and indazole analogs as glycogen synthase activators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indole and indazole analogs as glycogen synthase activators will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2671162